Prof. Damiano Caputo

Date of birth: 30/06/1977

2017 Fellow of the American College of Surgeons

2016 Second Level Master's Degree in Hepatobiliary Surgery at the Catholic University of the Sacred Heart of Rome.

2007 Specialization Diploma in General Surgery cum laude

2001 Degree in Medicine and Surgery cum laude from theUniversità Campus Bio-Medico di Roma.

Selected publications:

1) Caputo, D.; Coppola, A.; Quagliarini, E.; Di Santo, R.; Capriotti, A. L.; Cammarata, R.; Laganà, A.; Papi, M.; Digiacomo, L.; Coppola, R.; et al. Multiplexed Detection of Pancreatic Cancer by Combining a Nanoparticle-Enabled Blood Test and Plasma Levels of Acute-Phase Proteins. Cancers 2022, 14, 4658. https://doi.org/10.3390/ cancers14194658

2) Caputo, D.; Quagliarini, E.; Pozzi, D.; Caracciolo, G. Nanotechnology Meets Oncology: A Perspective on the Role of the Personalized Nanoparticle-Protein Corona in the Development of Technologies for Pancreatic Cancer Detection. Int. J. Mol. Sci. 2022, 23, 10591. https://doi.org/10.3390/ ijms231810591

3) Iorio, J.; Antonuzzo, L.; Scarpi, E.; D'Amico, M.; Duranti, C.; Messerini, L.; Sparano, C.; Caputo, D.; Lavacchi, D.; Borzomati, D.; et al. Prognostic Role of hERG1 Potassium Channels in Neuroendocrine Tumors of the Ileum and Pancreas. Int. J. Mol. Sci. 2022, 23, 10623. https://doi.org/10.3390/

4) Coppola, A.; La Vaccara, V.; Farolfi, T.; Fiore, M.; Cammarata, R.; Ramella, S.; Coppola, R.; Caputo, D. Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives.Biomedicines 2022, 10, 2091. https://doi.org/10.3390/

5) Coppola A, La Vaccara V, Farolfi T, Fiore M, Cascone C, Ramella S, Spoto S, Ciccozzi M, Angeletti S, Coppola R, Caputo D. Different Biliary Microbial Flora Influence Type of Complications after Pancreaticoduodenectomy: A Single Center Retrospective Analysis. J Clin Med. 2021 May 18;10(10):2180. doi:10.3390/jcm10102180. PMID: 34070003.

6) Coppola A, La Vaccara V, Fiore M, Farolfi T, Ramella S, Angeletti S, Coppola R, Caputo D. CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis. Front Oncol. 2021 May 27;11:690580. doi: 10.3389/fonc.2021.690580. PMID: 34123859; PMCID: PMC8190389.

7) Caputo D, Pozzi D, Farolfi T, Passa R, Coppola R, Caracciolo G. Nanotechnology and pancreatic cancer management: State of the art and further perspectives. World J Gastrointest Oncol. 2021 Apr 15;13(4):231-237. doi: 10.4251/wjgo.v13.i4.231. PMID: 33889275; PMC ID: PMC8040067.

8) Nappo G, Borzomati D, Zerbi A, Spaggiari P, Boggi U, Campani D, Mrowiec S, Liszka Ł, Coppola A, Amato M, Petitti T, Vistoli F, Montorsi M, Perrone G, Coppola R, Caputo D. The Role of Pathological Method and Clearance Definition for the Evaluation of Margin Status after Pancreatoduodenectomy for Periampullary Cancer. Results of a Multicenter Prospective Randomized Trial. Cancers (Basel). 2021 Apr 266;13(9):2097. doi: 10.3390/cancers13092097. PMID: 33926138; PMCID: PMC8123600.

9) Caputo D, Digiacomo L, Cascone C, Pozzi D, Palchetti S, Di Santo R, Quagliarini E, Coppola R, Mahmoudi M, Caracciolo G. Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer. Cancers (Basel). 2020 Dec 30;13(1):93. doi:10.3390/cancers13010093. PMID: 33396882; PMC ID: PMC7796289.